• 1
    Pugh DG 1951 Subperiosteal resorption of bone, a roentgenologic manifestation of primary hyperparathyroidism and renal osteodystrophy. Am J Roengenol 66:577586.
  • 2
    Parfitt AM 1977 The clinical and radiographic manifestations of renal osteodystrophy. In: DavidDJ (ed.) Perspectives in Hypertension and Nephrology: Calcium Metabolism in Renal Failure and Nephrolithiasis. J Wiley, New York, NY, USA, pp. 145195.
  • 3
    Meema HE, Oreopoulos DG, Rabinovich S, Husdan H, Rapoport A 1974 Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Relationship to osteosclerosis, osteitis fibrosa, and osteoid excess. Radiology 110:513522.
  • 4
    Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD 1971 Primary hyperparathyroidism: A prospective clinical study. Am J Med 50:670678.
  • 5
    Arnaud CD 1978 Hyperparathyroidism and renal failure. Kidney Int 4:8995.
  • 6
    Parfitt AM 2002 Recent contributions of iliac bone histomorphometry to understanding the anabolic effect of parathyroid hormone. IBMS BoneKEy Jan 29 20.1138/ibmske.2002017.
  • 7
    Dempster DW, Zhou H, Cosman F, Nieves J, Adachi JD, Fraher LJ, Watson PH, Lindsay B, Hodsman AB 2001 PTH treatment directly stimulates bone formation in cancellous and cortical bone in humans. J Bone Miner Res 16:S1;S179.
  • 8
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:18461863.
  • 9
    Parfitt AM 1977 Metacarpal cortical dimensions in hypoparathyroidism, primary hyperparathyroidism and chronic renal failure. Calcif Tissue Res 22(Suppl):329331.
  • 10
    Kleerekoper M, Villanueva AR, Mathews CHE, Rao DS, Pumo B, Parfitt AM 1983 PTH mediated bone loss in primary and secondary hyperparathyroidism. In: FrameB, PottsJTJr (eds.) Clinical Disorders of Bone Miner Metabolism. Excerpta Medica, Amsterdam, The Netherlands, pp. 200203.
  • 11
    Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB 1988 Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67:876881.
  • 12
    Garn SM, Poznanski AN, Larson KE 1976 Metacarpal lengths, cortical diameters and areas from the 10-state nutrition survey. In: Jaworski ZF (ed.) Proceedings of the First Workshop on Bone Morphometry. University of Ottawa Press, Ottawa, Canada, pp. 367391.
  • 13
    DeQueker J 1972 Bone Loss in Normal and Pathological Conditions. Leuven University Press, Leuven, Belgium.
  • 14
    Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B 1985 Irreversible bone loss in osteomalacia: Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest 76:24032412.
  • 15
    Carvalho RS, Scott JE, Suga DM, Yen EH 1994 Stimulation of signal transduction pathways in osteoblasts by mechanical strain potentiated by parathyroid hormone. J Bone Miner Res 9:9991011.
  • 16
    Balena R, Shih M-S, Parfitt AM 1992 Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women. J Bone Miner Res 7:14751482.
  • 17
    Parfitt AM 1980 Richmond Smith as a clinical investigator: His work on adult periosteal bone expansion, and on nutritional and endocrine aspects of osteoporosis, in the light of current concepts. Henry Ford Hosp Med J 28:95107.
  • 18
    Martin RB, Burr DB, Sharkey NA 1998 Skeletal Tissue Mechanics. Springer-Verlag, New York, NY, USA.
  • 19
    Khosla S, Melton LJ III, Wermers RA, Crowson CS, O'Fallon W, Riggs B 1999 Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res 14:17001707.
  • 20
    Epker BN, Frost HM 1966 Periosteal appositional bone growth from age two to age seventy in man. A tetracycline evaluation. Anat Rec 154:573.
  • 21
    Garn SM, Richman CG, Wanger B, Ascoli W 1967 Continuing bone growth throughout life: A general phenomenon. Am J Phys Anthropol 26:377380.
  • 22
    Lazenby RA 1990 Continuing periosteal apposition. I. Documentation, hypotheses and interpretation. Am J Phys Anthropol 82:451472.
  • 23
    Seeman E 2002 Pathogenesis of bone fragility in women and men. Lancet 359:18411850.
  • 24
    Uchida A, Kikuchi T, Shimomura Y 1988 Osteogenic capacity of cultured human periosteal cells. Acta Orthop Scand 158:173197.
  • 25
    Ali AA, O'Brien CA, Weinstein RS, Roberson P, Manolagas SC, Jikla RJ 2001 An inverse relationship between prevalence of osteoblast apoptosis and rate of bone formation with intermittent, but not sustained elevation of PTH in mice. J Bone Miner Res 16:S1;S178.
  • 26
    Parfitt AM 2002 The physiologic and pathogenetic significance of bone histomorphometric data. In: CoeFL, FavusMJ (eds.) Disorders of Bone Miner Metabolism, 2nd ed. Lippincott Williams and Wilkins, Philadelphia, PA, USA, pp. 409485.
  • 27
    Pead MJ, Skerry TM, Lanyon LE 1988 Direct transformation from quiescence to bone formation in the adult periosteum following a single brief period of bone loading. J Bone Miner Res 3:647656.
  • 28
    Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439446.